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ABSTRACT
Introduction: Celiac disease (CD) affects health-related quality 
of life (HRQOL) of patients suffering it. The exclusion of gluten 
from the diet (GFD) improves HRQOL, but involves difficulties in 
following the diet that could adversely affect HRQOL. 
Objective: To determine the effect of adherence to the diet 
on HRQOL of adult CD patients.
Methods: A prospective, cross-sectional, multicenter study of 
CD patients treated with a GFD for longer than 1 year. Adherence 
to the GFD was measured using the Morisky scale, and health 
status using the specific CD-QOL questionnaire and the generic 
EuroQol-5D questionnaire.
Results: 366 patients from 7 hospitals were included: 71.5% 
of patients reported a perfect treatment adherence, 23.5% 
unintentional poor adherence and 5% intentional poor adherence. 
Good adherence to a GFD was related to a higher mean score on 
the CD-QOL (75 vs. 68, respectively, p < 0.05) and EuroQol-5D 
(0.9 vs. 0.8, respectively, p < 0.05). Ease of adherence to a GFD 
was also related to a better HRQOL (total CD-QOL score of 82 vs. 
67 in patients who consider the GFD difficult to follow, p < 0.05). 
Good symptom control was also related to a better HRQOL (total 
CD-QOL score of 78 vs. 67 in asymptomatic vs. symptomatic 
patients, p < 0.01). The worse scored dimension of CD-QOL was 
related to “inadequate treatment.”
Conclusions: In CD, good adherence to a GFD and adequate 
symptom control result in improved HRQOL. Many patients 
consider that the lack of therapeutic alternatives to diet worsens 
their quality of life.
Key words: Celiac disease. Quality of life. Gluten-free diet. 
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INTRODUCTION
Celiac disease (CD), due to its chronic nature, impact on 
health, psychological distress, social and family connotations, 
and need for permanent treatment, adversely affects quality of 
life (HRQOL) of patients. There is proven evidence that hav-
ing CD affects the general perception of HRQOL and the feel-
ing of well-being (1,2), which has been associated with factors 
such as the presence of symptoms, female gender, associated 
diseases, having fatigability, and not having received treat-
ment (3,4). In addition, many studies have shown repeated-
ly that starting the treatment, with complete and permanent 
exclusion of gluten from the diet (GFD) achieves not only 
to relieve symptoms but also to improve HRQOL (5,6). The 
improvement in HRQOL induced by a GFD is substantial, 
though this good response is not apparent in patients with 
clinically silent CD or diagnosed by serology only (7). This is 
probably due to the fact that asymptomatic patients diagnosed 
only by serology have an unchanged quality of life (8-11).
However, following a GFD also generates difficulties 
and limitations in the life of patients with CD under treat-
ment. A national survey of members of the Canadian Celi-
ac Association revealed difficulties in following a GFD in 
44% of patients, with limitations in daily life from avoid-
ing restaurants, avoiding travel, etc. (12). A similar study, 
where a survey was sent to the members of the German 
Coeliac Society, showed that, though the GFD improved 
patients’ symptoms and HRQOL, they continued to have 
poorer anxiety, fatigue and quality of life scores measured 
with the generic SF-36 questionnaire than the reference 
general population (13). Also an American study that 
conducted a survey of members of the Westchester Celiac 
Sprue Support Group found that following a GFD had a 
negative impact in some areas such as family in 67% of 
cases or work in 41% of cases (14). A more recent Amer-
ican study confirmed the negative impact of the GFD on 
the life of patients by applying the generic FS-12 question-
naire (15). Similarly, a survey directed to members of the 
Coeliac UK Charity showed that, although 96% of celi-
acs reported correct compliance with the GFD, impaired 
HRQOL persisted with regard to exclusion from social 
and leisure activities (16). It is not surprising, in view of 
the above, that celiac patients may continue to experience 
a substantial long-term burden by following the diet (17).
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Adequate treatment adherence, in this case to a GFD, 
is a determining factor in improving the health of celiac 
patients and for improving their HRQOL (18). Noncompli-
ers or partial compliers of treatment are those with poorer 
scores on generic quality of life questionnaires such as 
the WHOQOL-BREF or SF-36, both the overall score and 
most their domains (19-21). In a prospective study of celi-
ac patients who started a GFD, it was shown that HRQOL 
measured according to SF-36 improved during the first 
year of follow-up, but that HRQOL worsened significant-
ly at 4 years of follow-up, which was explained by the 
authors by a lack of strict compliance to the GFD (22). The 
association of adequate compliance with a GFD and better 
HRQOL is not limited to adult celiac patients, but also has 
been reproduced in adolescents in whom a study showed 
that noncompliers with CD have poorer HRQOL, more 
physical and family problems and greater concern about 
their disease (23). However, there is some disagreement on 
health perception and adherence to the GFD since there are 
also other authors who, also using generic questionnaires, 
such as SF-36, have observed that the degree of compli-
ance to the GFD is not associated with quality of life (24-
26). In this regard, it has been observed that asymptomatic 
patients diagnosed by serology, in contrast to what occurs 
with symptomatic cases, may even experience deteriora-
tion in their health perception during following of a GFD 
(27). A randomized clinical trial analyzing the effect of an 
online interactive intervention to optimize adherence to 
the GFD showed that, although the intervention program 
effectively improve adherence to the GFD, measurements 
of HRQOL did not differ between patients who followed 
the interactive program and controls (28). This disagree-
ment in the effect of adherence to the GFD on HRQOL 
of celiac patients could be related to the use of generic 
questionnaires instead of specific questionnaires for celiac 
disease, since they may be more sensitive to changes in 
HRQOL in the specific situation of celiac patients.
In order to improve the result of the generic question-
naires for measuring HRQOL in celiac disease, specific 
questionnaires for application in adult celiac patients have 
recently been designed, such as the Coeliac Quality of 
Life Questionnaire (CD-QOL) and Celiac Disease Ques-
tionnaire (CDQ) (29,30). The purpose of this project was 
therefore to examine the effect of adherence to the GFD 
on health perception of celiac patients measured using 
a specific questionnaire. A study was conducted in pre-
viously diagnosed celiac patients treated with a GFD in 
which adherence to the GFD was related to quality of life 
assessed with the specific questionnaire CD-QOL, because 
it is the only currently specific questionnaire translated and 
validated to Spanish available (31).
MATERIALS AND METHODS
A prospective, cross-sectional, multicenter, observational study 
was designed to establish the influence of following the GFD on 
HRQOL of celiac patients. The study was approved by the Ethics 
Committee of the Hospital Universitari Vall d’Hebron (Barcelona, 
Spain), with code PRAG254-2012.
The study included adult patients with celiac disease previously 
diagnosed according to the commonly accepted criteria (positive 
serum-IgA-tissue-transglutaminase antibodies with compatible 
endoscopic biopsy of duodenum) (32,33). 
In order to participate in the study, patients had to be between 
16 and 75 years of age, and have a duration of celiac disease since 
diagnosis greater than one year. All patients received treatment with 
a GFD. Patients with celiac disease who could not read or understand 
questionnaires, with other relevant concomitant chronic diseases, or 
who refused to sign informed consent were excluded from the study. 
Procedure
Patients who met the criteria for participation in the study were 
explained the protocol and signed an informed consent form. The 
quality of life and treatment adherence questionnaires were then 
administered, and clinical and epidemiological data were collected. 
The variables measured in this study phase were:
Quality of life
For determination of quality of life, the Spanish version of the 
specific questionnaire for patients with celiac disease CD-QOL (31), 
and the generic EuroQol-5D questionnaire were administered. The 
latter questionnaire is a generic questionnaire validated in Spanish 
consisting of two parts. The first part assesses health state through 
five dimensions: Mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression. Each of these dimensions includes three 
items related to three severity levels. As the result, 243 different 
health states may be obtained. In the second part, patients score 
their health state on a visual analogue scale ranging from 0 (worst 
imaginable health state) to 100 (best imaginable health state).
As a specific measurement of HRQOL, the CD-QOL was chosen 
because it is a specific questionnaire and it has been previously trans-
lated and validated in Spanish (31). The CD-QOL is a self-admin-
istered questionnaire consisting of 20 items, to be answered using a 
Likert scale, distributed into 4 dimensions: Dysphoria, limitations, 
health concerns, and inadequate treatment –that should be answered 
on a Likert scale. Administration of the questionnaire yields an over-
all score expressed on a scale of 0 (worst quality of life) to 100 (best 
quality of life), and four domains, each expressed on the same 0-100 
scale, where 100 corresponds to the best quality of life. The instruc-
tions given in the original publication were followed to calculate the 
score on the questionnaire.
Monitoring of adherence to the GFD
Compliance with the GFD was assessed using the adaptation of 
the self-administered questionnaire by Morisky et al. (36). Since this 
questionnaire was originally described for medication adherence, 
it was adapted to be applied to adherence to the GFD, and a fifth 
response was added: “I never forget to follow the diet”. This adap-
tation has previously been used in other studies of adherence to a 
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GFD in celiac disease (37). This questionnaire consists of four items 
referring to treatment compliance, which are answered using a binary 
scale (yes/no). The first two questions relate to unintentional non-ad-
herence (I sometimes forget to follow the diet/I sometimes am not 
very careful in following the diet), while the last two questions relate 
to intentional non-adherence (when I feel better, I sometimes stop the 
diet/if I do not feel well, I sometimes stop the diet). If the answer to 
either of the questions 3 or 4 is yes, the patient is considered to have 
voluntarily discontinued the diet. If answer to either of the questions 
1 or 2 is yes, the patient is considered to have unintentional non-
compliance with due to carelessness or forgetfulness. If no question 
is answered yes, diet adherence is considered to be good or perfect.
Statistical analysis
In accordance with the established objective, for statistical analy-
sis, patients were stratified into three groups according to the degree 
of adherence to the GFD: Good compliance, unintentional noncom-
pliance, and intentional noncompliance. Normality of variables was 
analyzed using a Kolmogorov test. Since some variables did not 
follow a normal distribution, descriptive statistics was performed 
using the median and 25-75 percentiles, and comparative statistics 
between groups using the respective nonparametric tests (Spear-
man correlation to correlate the CD-QOL with the EuroQol-5D and 
EIDF, and the Mann-Whitney or Kruskal-Wallis tests as necessary, 
to determine the existence of statistical differences between quan-
titative variables). A value of p < 0.05 was considered statistically 
significant. For statistical calculation, the GraphPad Prism version 
5.00 for Windows program was used.
RESULTS 
The study was conducted in seven Spanish hospitals, 
where the questionnaires were administered to a total of 
366 adult celiac patients receiving a GFD for a median of 
4 years. Table I summarizes the main characteristics of the 
patients included. As regards following their diet, most 
patients (71.5%) stated they never forget to follow the diet, 
which was considered a perfect adherence to treatment. Of 
the remaining patients, 23.5% had unintentional noncom-
pliance and 5.0% had intentional noncompliance of the diet 
(Table II). Fifteen patients did not answer Morisky test or 
did so incorrectly, and were not included in the statistical 
analysis of the study.
Effect of following the gluten-free diet on HRQOL
The overall score on the CD-QOL questionnaire by 
degree of adherence to the GFD according to the results of 
the Morisky scale are shown in figure 1. It can be seen that 
the score obtained by the 251 celiac patients who reported 
perfect adherence to the GFD is significantly higher than 
that obtained by 83 celiac patients who reported unintend-
ed noncompliance and the 17 celiac patients who reported 
intentional noncompliance. This reflects that correct adher-
ence to the GFD is associated with better quality of life 
assessed by the specific questionnaire.
The differences in quality of life according to adher-
ence to the GFD established according to the generic Euro-
Qol-5D questionnaire were similar. Comparisons were 
made of the median index and median visual analogue 
scale of the EuroQol-5D between the groups with differ-
ent degrees of adherence to the GFD (Fig. 2). The differ-
ences obtained in the EuroQol-5D score were statistically 
significant between the group with perfect adherence to 
the GFD and the groups with unintentional or intentional 
noncompliance, for both index (p = 0.01) and the visual 
analogue scale of the EuroQol-5D (p < 0.05). This indi-
cates that good adherence to the GFD is associated with a 
better quality of life.
Table I. Epidemiological characteristics of patients 
included in the study 
Variables
Total number 366
Age 40.0 [28.0-49.2]
Sex (% women) 70.0%
Smoking (% smokers) 16.1%
Time since onset (months) 48.0 [24.0-113.5]
Classic symptoms (%) 24.8%
Associated diseases (%) 22.9%
Education (none / primary / secondary / 
university)
5 / 68 / 157 / 131
Civil status (single / married / other) 151 / 183 / 322
PLACE OF RESIDENCE
(< 1•105 / 1•105 to 5•105 / > 5•105 
inhabitants
174 / 156 / 36 
Results are given in absolute numbers, percentage, or medians with [25th-75th 
percentile].
Table II. Degree of adherence to diet according to results 
of Morisky scale
I never forget to follow the 
GFD
251 (71.5%)
Good 
compliance
I sometimes forget to follow 
the GFD
49 (13.9%) Noncompliance
I am sometimes not very 
careful
34 (9.6%) Unintentional
When I feel well I sometimes 
stop the diet
13 (3.8%) Noncompliance
If I don’t feel well I sometimes 
stop the diet
4 (1.2%) Intentional
Results expressed in absolute terms values and percentage (in parentheses) of 
patients included in the statistical analysis. Fifteen patients who did not answer 
the Morisky test or did so incorrectly were excluded from the analysis.
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The results obtained in the four domains of the CD-QOL 
according to the degree of adherence to the GFD are shown 
in table III. Analysis of the results of the CD-QOL dimen-
sions suggests that in all groups following the GFD the 
worst scored dimension was that related to “inadequate 
treatment.” Individual results of each domain for each of the 
three degrees of adherence to the GFD show that the “dys-
phoria” and “health concerns” dimensions are significantly 
better scored in the group with complete adherence than in 
the groups with nonadherence (Kruskal-Wallis test, p < 0.05 
for both). From these results it can be deduced that the fact of 
suffering a celiac disease and having to follow a dietary treat-
ment negatively impacts perceived quality of life by patients, 
but if they correctly follow the diet they report the perception 
of having fewer health concerns and better dysphoria.
To analyze the importance of achieving a good HRQOL 
measured according to the CDQOL specific questionnaire, 
the results for adherence, symptom improvement (patients 
were asked if symptoms had disappeared, had improved or 
remained the same or worse) and presence of symptoms 
related to the disease (patients were asked if they had any 
symptoms or remained asymptomatic) were stratified based 
on whether the overall CD-QOL score was above 60 percen-
tile (good quality of life, n = 274) or below the 40 percentile 
(poor quality of life, n = 28). According to this distribution, 
the degree of adherence was independent of whether quality 
of life was good or bad (complete adherence to the GFD in 
67% and 70% respectively, p = ns). However, having a good 
quality of life was significantly related to symptom improve-
ment and the absence of symptoms at study entry (Fig. 3).
DISCUSSION
Celiac disease is of great importance because of its 
increasing incidence, occurrence at any age with a broad 
range of clinical manifestations, sometimes with a consid-
erable delay in diagnosis and requiring lifelong treatment 
(38). The purpose of this study was to examine the rela-
tionship between adherence to the GFD and health percep-
tion of celiac patients, measured using a specific question-
naire validated in the study population, the CD-QOL. A 
prospective, crossover multicenter study was conducted in 
351 celiac patients previously diagnosed and treated with 
GFD, in which adherence to the GFD measured according 
to the Morisky test was related to HRQOL. The results of 
the present study show that patients correctly following 
the GFD have better HRQOL. The analysis by quality of 
life dimensions suggests that better HRQOL is associated 
with less dysphoria and fewer health concerns. The poorer 
scored dimension in all groups of adherence to the GFD 
was “inadequate treatment.” This result can be interpreted 
in the sense that celiac patients on treatment perceive that 
not having other alternatives to the gluten-free diet for con-
trolling the disease limits their quality of life. It was not an 
objective of the study to determine the reasons for failure 
Fig. 1. Median and percentiles [25-75] of overall score on CD-QOL 
questionnaire by degree of adherence to the GFD. Celiac patients with 
perfect adherence to the GFD (n = 251) achieved a significantly higher 
score (* = p < 0.05) than patients reporting an unintentional (n = 83) or 
intentional (n = 17) nonadherence.
Fig. 2. Median and percentiles [25-75] of EuroQol-5D index (A) and 
visual analogue scale (B) according to the degree of adherence to the 
GFD. Celiac patients who have perfect adherence to the GFD obtained a 
significantly higher EuroQol-5D index (*p = 0.01) and score on the visual 
analogue scale (* = p < 0.05) than patients reporting unintentional or 
intentional nonadherence.
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of treatment adherence or potential factors involved in this, 
and therefore psychological profiles of patients were not 
established that might have influenced this (39).
Achieving a good HRQOL in celiac patients with the 
GFD is important because those who obtain a good score 
on the CD-QOL questionnaire are those who have obtained 
a good response to diet and remain free of disease symp-
toms. This finding confirms the need for taking all neces-
sary measures to achieve good compliance with the GFD.
The rate of correct adherence to the GFD in patients 
included in the study was 71.5%. This value is consistent 
with the expected rate, because other series have pub-
lished a rate of good adherence of up to 75% in adoles-
cents (40) or from 70-81% in adults (41,42). Most pub-
lications have analysed adherence to the GFD and their 
results have shown that correct adherence to treatment 
achieves a good symptomatic response. However, there is 
much less information on how the degree of adherence is 
related to changes in health perception of celiac patients. 
The present study shows that patients with partial or no 
adherence have a poorer HRQOL than those defined as 
good compliers of the GFD. The results of this study agree 
with those previously published, which had suggested the 
presence of a relationship between HRQOL and adherence 
to the GFD, so that using the SF-36 generic instrument it 
was shown that, with regard to the HRQOL before start-
ing GFD, patients who have better HRQOL after 4 years 
of follow-up are those who have strict compliance with 
the diet (43). Adherence has thus been advocated as an 
independent factor involved in HRQOL of celiac patients 
(44). One limitation of the study, due to its design, is the 
lack of a measurement of quality of life before starting 
treatment. This would allow determining the degree of gain 
in perception of health measured with specific instruments 
for celiac disease according to the degree of adherence to 
the diet, a very interesting aspect, but which remains open 
for future prospective studies designed for this purpose.
From the results of this study, it can be established that 
the better the quality of life of celiac patients the better is 
their clinical response and the fewer the symptoms they 
have. This is another reason to promote perfect adherence to 
the GFD. However, treatment of celiac disease also induces 
negative subjective appraisals, so that it has been suggest-
ed that celiac patients report high concern about treatment, 
even worse than in other gastrointestinal chronic gastroin-
testinal diseases such as gastroesophageal reflux disease 
(45). The factors that have been related to concern about 
treatment in celiac disease include the high cost of food, 
having to eat out, problems with meals at school, limitations 
in the time to prepare food and poor treatment adherence. In 
the same study, this low adherence to the GFD was s found 
to be associated with a greater severity of symptoms and a 
worse perception of the importance of treatment, therefore 
justifying another reason to enhance adherence to the GFD 
in celiac patients. Other studies have shown that maintaining 
the GFD has a negative impact on the life of celiac patients, 
who report difficulties in eating out, travelling or family 
life (14). Taking together all these data, it can be concluded 
that complete adherence to the GFD results in significant 
benefits for the health and quality of life of celiac patients, 
but this is also at the expense of creating a concern and a 
limitation for certain activities of daily life. It could also 
be suggested alternative explanations for the findings of 
the study, as being celiac patients with worse quality of life 
those with lower adherence to the gluten-free diet.
Table III. Median score and percentiles [25-75] obtained in each domain of the CD-QOL in the groups distributed according  
to degree of adherence to the gluten-free diet 
Perfect adherence (n = 251) Unintentional noncompliance (n = 83) Intentional noncompliance (n = 17)
Overall 75.0 [61.2-83.7] # 68.7 [55.0-78.7] 68.7 [56.2-75.6]
Dysphoria 94.0 [81.0-100.0]# 88.0 [75.0-100.0] 94.0 [69.0-97.0]
Limitations 75.0 [58.0-89.0] 75.0 [58.0-89.0] 67.0 [54.5-79.5]
Health concerns 75.0 [55.0-90.0]# 70.0 [45.0-90.0] 60.0 [47.5-70.0]
Inadequate treatment 50.0 [25.0-63.0] 50.0 [25.0-63.0] 50.0 [25.0-50.0] 
Results are given on a 0-100 scale, where 100 correspond to the best quality of life. The worst scored dimension in all degree of treatment adherence groups was “inad-
equate treatment”, p < 0.05. (# = p < 0.05 in the same domain versus other degrees of adherence to the GFD).
Fig. 3. Effect to having good or poor quality of life according to the 
overall CD-QOL score was above the 60th percentile or below the 40th 
percentile, respectively, in adherence to the GFD and symptoms. Having 
a good quality of life (PC > 60) was significantly related to improvement 
in symptoms and the absence of symptoms at the time of inclusion.
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In conclusion, the results of this study suggest that most 
celiac patients consider they correctly follow the GFD. 
Adequate compliance with the GFD is related to better 
quality of life measured with a specific instrument for 
celiac patients and this is associated with good control of 
symptoms. On the other hand, according to the results of 
the “inadequate treatment” dimension of the CD-QOL, 
celiac patients on diet treatment perceive that not having 
other alternatives to the gluten-free diet for controlling the 
disease limits their quality of life.
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